Physician

Nischala Ammannagari, MD

According to 2025 Medicare claims, Nischala Ammannagari, MD (NPI: 1033405154) practices hematology/oncology in the Albany-Schenectady-Troy, NY market, with the plurality of this provider's patient population coming from Albany, NY. This provider's primary affiliated billing organization is NEW YORK ONCOLOGY HEMATOLOGY, P.C. (NPI: 1609863448; TIN: 141799724) and primary practice location at 12206-5013.

Ammannagari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 944 traditional Medicare patients, billed 125,052 HCPCS/CPT codes, and received $1,799,216 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 1,654 prescription claims across 334 beneficiaries totaling $2,711,557 in drug costs, led by Ibrance (Palbociclib). 2023 DME data shows 25 claims. Open Payments data shows 9 records totaling $5,190. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $55,755 to $1,799,216. Similarly, Part D prescription costs have risen steadily, from $149,794 to $2,711,557. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.